There are 12 resources available
Welcome and Learning Objectives Introduction
Presenter: K Herrmann, DE, and A. G. Omlin, CH
Session: Welcome and introduction
Resources:
Slides
Webcast
Definition and therapeutic concepts of therapeutic radionuclides
Presenter: K. Herrmann, DE
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Webcast
Regulatory challenges in the development of theranostics
Presenter: Michael Nader, DE
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Webcast
Radioiodine therapy in thyroid cancer
Presenter: D. Deandreis, FR
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Webcast
Landscape of systemic therapies for thyroid malignancies
Presenter: J. A. Krajewska, PL
Session: Session 1 - Introduction to Theranostics and Systemic Therapies
Resources:
Slides
Webcast
Overview NET: Epidemiology, disease specific characteristics and challenges
Presenter: L. Graven, NL
Session: Session 2 - NETs as Role Model for Theranostics
Resources:
Slides
Webcast
PRRT in NET: What is the standard?
Presenter: W. Fendler, DE
Session: Session 2 - NETs as Role Model for Theranostics
Resources:
Slides
Webcast
Systemic therapies for NETs (Other than PRRT)
Presenter: M. Pavel, DE
Session: Session 2 - NETs as Role Model for Theranostics
Resources:
Slides
Webcast
Biology in Advanced Prostate Cancer with a Special Focus on PSMA across the Disease Spectrum (Primary Tumour, Upregulation with AR Targeted Therapies, Heterogeneity, ...)
Presenter: E. Compérat, AT
Session: Session 3 - Expanding Theranostics to Prostate Cancer
Resources:
Slides
Webcast
Treatment Landscape in Advanced Prostate Cancer
Presenter: A. G. Omlin, CH
Session: Session 3 - Expanding Theranostics to Prostate Cancer
Resources:
Slides
Webcast